Data Frame Summary

gcon

Dimensions: 56 x 65
Duplicates: 1
No Variable Stats / Values Freqs (% of Valid) Graph Valid Missing
1 Event Name [character] 1. FIRMA CI I EVALUACIÓ BASA
51(100.0%)
 51 (91.1%) 5 (8.9%)
2 DATA D'INCLUSIÓ AL PROGRAMA [POSIXct, POSIXt] min : 2014-01-16 med : 2016-03-31 max : 2020-11-17 range : 6y 10m 1d 51 distinct values 51 (91.1%) 5 (8.9%)
3 Edat [numeric] Mean (sd) : 55.6 (12.1) min < med < max: 18 < 58 < 70 IQR (CV) : 18 (0.2) 29 distinct values 51 (91.1%) 5 (8.9%)
4 Sexe [character] 1. 0 2. 1 3. Femenino=0 4. Masculino=1
21(39.6%)
30(56.6%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
5 ETIOLOGIA INSUFICIÈNCIA CARDIACA [character] 1. ALTRES 2. AMILOIDOSIS 3. ISQUÈMICA 4. MCD 5. MCH 6. TÒXICA
7(13.7%)
1(2.0%)
19(37.3%)
17(33.3%)
5(9.8%)
2(3.9%)
 51 (91.1%) 5 (8.9%)
6 Tipo de trasplante [character] 1. Cardíaco 2. Retrasplante
50(98.0%)
1(2.0%)
 51 (91.1%) 5 (8.9%)
7 NIVELL EDUCATIU MÀXIM [character] 1. BÀSICA 2. SECUNDÀRIA 3. SUPERIOR
1(33.3%)
1(33.3%)
1(33.3%)
 3 (5.4%) 53 (94.6%)
8 CUIDADOR [character] 1. NO AJUDA, INDEPENDENT
10(100.0%)
 10 (17.9%) 46 (82.1%)
9 FUMADOR [character] 1. 0 2. 1 3. 2 4. Exfumador=1 5. fumador=2 6. No=0
22(40.7%)
28(51.9%)
1(1.9%)
1(1.9%)
1(1.9%)
1(1.9%)
 54 (96.4%) 2 (3.6%)
10 EN0L [character] 1. 0 2. 1 3. No=0 4. Sí=1
47(88.7%)
4(7.5%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
11 DATA ENTRADA A LLISTA D'ESPERA TXC [POSIXct, POSIXt] min : 2013-01-16 med : 2015-07-15 max : 2020-09-17 range : 7y 8m 1d 51 distinct values 51 (91.1%) 5 (8.9%)
12 TEMPS EN LLISTA TRASPLANTAMENT [numeric] Mean (sd) : 174.4 (175.4) min < med < max: 1 < 102 < 813 IQR (CV) : 262 (1) 47 distinct values 51 (91.1%) 5 (8.9%)
13 Nº INGRESSOS EN L'ÚLTIM ANY PER DESCOMPENSACIÓ [numeric] Mean (sd) : 0.8 (1) min < med < max: 0 < 1 < 4 IQR (CV) : 1 (1.2)
0:24(48.0%)
1:17(34.0%)
2:5(10.0%)
3:3(6.0%)
4:1(2.0%)
 50 (89.3%) 6 (10.7%)
14 ASA [numeric] 1 distinct value
4:51(100.0%)
 51 (91.1%) 5 (8.9%)
15 CLASSE FUNCIONAL: NYHA [numeric] Mean (sd) : 3.2 (0.6) min < med < max: 1 < 3 < 4 IQR (CV) : 1 (0.2)
1:1(2.0%)
2:2(3.9%)
3:33(64.7%)
4:15(29.4%)
 51 (91.1%) 5 (8.9%)
16 INTERMACS [numeric] 1 distinct value
7:1(100.0%)
 1 (1.8%) 55 (98.2%)
17 Charlson [numeric] Min : 3 Mean : 4.3 Max : 5
3:1(33.3%)
5:2(66.7%)
 3 (5.4%) 53 (94.6%)
18 KARNOFSKY [logical] All NA's 0 (0.0%) 56 (100.0%)
19 DASI [character] 1. 24.2 2. 4.5 3. 7.2
1(33.3%)
1(33.3%)
1(33.3%)
 3 (5.4%) 53 (94.6%)
20 CSHA [character] 1. 4 Vulnerable, símptomes l 2. 5 Fragilitat lleu 3. 6 Fragilitat moderada, re
4(36.4%)
4(36.4%)
3(27.3%)
 11 (19.6%) 45 (80.4%)
21 COMORBIDITATS (choice=HTA) [character] 1. 0 2. 1 3. No=0 4. Sí=1
12(22.6%)
39(73.6%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
22 COMORBIDITATS (choice=DSLP) [character] 1. 0 2. 1 3. No=0 4. Sí=1
27(50.9%)
24(45.3%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
23 COMORBIDITATS (choice=DM) [character] 1. 0 2. 1 3. No=0 4. Sí=1
40(75.5%)
11(20.8%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
24 COMORBIDITATS (choice=VASCULOPATIA) [character] 1. 0 2. 1 3. No=0 4. Sí=1
45(84.9%)
6(11.3%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
25 COMORBIDITATS (choice=IAM) [character] 1. 0 2. 1 3. No=0 4. Sí=1
31(58.5%)
20(37.7%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
26 COMORBIDITATS (choice=HIPOTIROIDISME) [character] 1. 0 2. 1 3. No=0 4. Sí=1
43(81.1%)
8(15.1%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
27 COMORBIDITATS (choice=SAHS) [character] 1. 0 2. 1 3. No=0 4. Sí=1
43(81.1%)
8(15.1%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
28 COMORBIDITATS (choice=AVC) [character] 1. 0 2. 1 3. No=0 4. Sí=1
43(81.1%)
8(15.1%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
29 COMORBIDITATS (choice=MPOC, ASMA) [character] 1. 0 2. 1 3. No=0 4. Sí=1
34(64.2%)
17(32.1%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
30 COMORBIDITATS (choice=IRC) [character] 1. 0 2. 1 3. No=0 4. Sí=1
30(56.6%)
21(39.6%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
31 COMORBIDITATS (choice=OBESITAT) [character] 1. 0 2. 1 3. No=0 4. Sí=1
42(79.2%)
9(17.0%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
32 COMORBIDITATS (choice=CIRURGIA CARDÍACA PRÈVIA) [character] 1. 0 2. 1 3. No=0 4. Sí=1
38(71.7%)
13(24.5%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
33 MEDICACIÓ ACTUAL (choice=BETABLOQUEJANTS) [character] 1. 0 2. 1 3. No=0 4. Sí=1
10(18.9%)
41(77.4%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
34 MEDICACIÓ ACTUAL (choice=VERAPAMIL / DILTIAZEM) [character] 1. 0 2. 1 3. No=0 4. Sí=1
50(94.3%)
1(1.9%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
35 MEDICACIÓ ACTUAL (choice=ESTATINES) [character] 1. 0 2. 1 3. No=0 4. Sí=1
23(43.4%)
28(52.8%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
36 MEDICACIÓ ACTUAL (choice=AMIODARONA) [character] 1. 0 2. 1 3. No=0 4. Sí=1
37(69.8%)
14(26.4%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
37 MEDICACIÓ ACTUAL (choice=LEVOSIMENDAN) [character] 1. 0 2. 1 3. No=0 4. Sí=1
33(62.3%)
18(34.0%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
38 MEDICACIÓ ACTUAL (choice=ANTICOAGULANTS ORALS) [character] 1. 0 2. 1 3. No=0 4. Sí=1
14(26.4%)
37(69.8%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
39 MEDICACIÓ ACTUAL (choice=SALBUTAMOL) [character] 1. 0 2. 1 3. No=0 4. Sí=1
49(92.5%)
2(3.8%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
40 MEDICACIÓ ACTUAL (choice=NITRATS) [character] 1. 0 2. 1 3. No=0 4. Sí=1
47(88.7%)
4(7.5%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
41 MEDICACIÓ ACTUAL (choice=DIGOXINA) [character] 1. 0 2. 1 3. No=0 4. Sí=1
39(73.6%)
12(22.6%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
42 Tratamiento con Levosimendán [character] 1. 0 2. 1 3. No=0 4. Sí=1
37(69.8%)
14(26.4%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
43 Inicio Levosimendán [logical] All NA's 0 (0.0%) 56 (100.0%)
44 DATA INICI LEVOSIMENDAN [POSIXct, POSIXt] min : 2013-10-05 med : 2017-06-28 12:00:00 max : 2020-02-25 range : 6y 4m 20d 18 distinct values 18 (32.1%) 38 (67.9%)
45 HIPERTENSIÓ PULMONAR [character] 1. LLEUGERA 2. MODERADA 3. NO 4. SEVERA
9(17.6%)
12(23.5%)
14(27.5%)
16(31.4%)
 51 (91.1%) 5 (8.9%)
46 Tratamiento de la HTP [character] 1. 0 2. 1 3. No=0 4. Sí=1
34(64.2%)
17(32.1%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
47 Fármaco HTP (choice=Bosentán) [character] 1. 0 2. 1 3. No=0 4. Sí=1
42(79.2%)
9(17.0%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
48 Fármaco HTP (choice=Sildenafilo) [character] 1. 0 2. 1 3. No=0 4. Sí=1
40(75.5%)
11(20.8%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
49 VALVULOPATIA? [character] 1. No 2. Yes
2(4.0%)
48(96.0%)
 50 (89.3%) 6 (10.7%)
50 Insuficiència / Estenosis? [character] 1. Estenosis 2. Insuficiència
1(2.1%)
47(97.9%)
 48 (85.7%) 8 (14.3%)
51 Vàlvula/es afectada (choice=MITRAL) [character] 1. 0 2. 1 3. No=0 4. Sí=1
14(26.4%)
37(69.8%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
52 Vàlvula/es afectada (choice=AÒRTICA) [character] 1. 0 2. 1 3. No=0 4. Sí=1
46(86.8%)
5(9.4%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
53 Vàlvula/es afectada (choice=TRICÚSPIDE) [character] 1. 0 2. 1 3. No=0 4. Sí=1
26(49.1%)
25(47.2%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
54 Vàlvula/es afectada (choice=PULMONAR) [character] 1. 0 2. No=0 3. Sí=1
51(96.2%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
55 GRAU DE SEVERITAT (choice=LLEU) [character] 1. 0 2. 1 3. No=0 4. Sí=1
37(69.8%)
14(26.4%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
56 GRAU DE SEVERITAT (choice=MODERADA) [character] 1. 0 2. 1 3. No=0 4. Sí=1
35(66.0%)
16(30.2%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
57 GRAU DE SEVERITAT (choice=SEVERA) [character] 1. 0 2. 1 3. No=0 4. Sí=1
33(62.3%)
18(34.0%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
58 FRACCIÓ D'EJECCIÓ VE % [numeric] Mean (sd) : 25.4 (11.1) min < med < max: 10 < 25 < 67 IQR (CV) : 8.5 (0.4) 20 distinct values 51 (91.1%) 5 (8.9%)
59 ARRÍTMIA (choice=NO) [character] 1. 0 2. 1 3. No=0 4. Sí=1
41(77.4%)
10(18.9%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
60 ARRÍTMIA (choice=ACXFA) [character] 1. 0 2. 1 3. No=0 4. Sí=1
20(37.7%)
31(58.5%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
61 ARRÍTMIA (choice=BAV) [character] 1. 0 2. 1 3. No=0 4. Sí=1
48(90.6%)
3(5.7%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
62 ARRÍTMIA (choice=ALTRES) [character] 1. 0 2. 1 3. No=0 4. Sí=1
26(49.1%)
25(47.2%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
63 PORTADOR MCP O DAI (choice=NO) [character] 1. 0 2. 1 3. No=0 4. Sí=1
43(81.1%)
8(15.1%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
64 PORTADOR MCP O DAI (choice=MARCAPAS) [character] 1. 0 2. 1 3. No=0 4. Sí=1
42(79.2%)
9(17.0%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)
65 PORTADOR MCP O DAI (choice=DAI) [character] 1. 0 2. 1 3. No=0 4. Sí=1
10(18.9%)
41(77.4%)
1(1.9%)
1(1.9%)
 53 (94.6%) 3 (5.4%)

Generated by summarytools 0.9.9 (R version 4.0.2)
2021-06-27

Data Frame Summary

gint

Dimensions: 49 x 85
Duplicates: 1
No Variable Stats / Values Freqs (% of Valid) Graph Valid Missing
1 DATA D'INCLUSIÓ AL PROGRAMA [POSIXct, POSIXt] min : 2017-07-10 med : 2019-02-18 max : 2020-11-16 range : 3y 4m 6d 40 distinct values 45 (91.8%) 4 (8.2%)
2 Edat [numeric] Mean (sd) : 53.6 (14.4) min < med < max: 0 < 60 < 70 IQR (CV) : 15 (0.3) 24 distinct values 45 (91.8%) 4 (8.2%)
3 Sexe [character] 1. Femení 2. Masculí
9(20.0%)
36(80.0%)
 45 (91.8%) 4 (8.2%)
4 ETIOLOGIA INSUFICIÈNCIA CARDIACA [character] 1. ALTRES 2. AMILOIDOSIS 3. ISQUÈMICA 4. MCD 5. MCH
6(13.3%)
2(4.4%)
19(42.2%)
12(26.7%)
6(13.3%)
 45 (91.8%) 4 (8.2%)
5 Tipo de trasplante [character] 1. Cardíaco 2. Cardiohepático 3. Cardiorrenal 4. Retrasplante
39(86.7%)
1(2.2%)
3(6.7%)
2(4.4%)
 45 (91.8%) 4 (8.2%)
6 NIVELL EDUCATIU MÀXIM [character] 1. BÀSICA 2. SECUNDÀRIA 3. SUPERIOR 4. UNIVERSITARI
11(24.4%)
22(48.9%)
7(15.6%)
5(11.1%)
 45 (91.8%) 4 (8.2%)
7 CUIDADOR [character] 1. FAMILIAR 2. NO AJUDA, INDEPENDENT
5(11.9%)
37(88.1%)
 42 (85.7%) 7 (14.3%)
8 FUMADOR [character] 1. EX-FUMADOR 2. NO 3. SI
31(68.9%)
12(26.7%)
2(4.4%)
 45 (91.8%) 4 (8.2%)
9 ENOL [character] 1. NO 2. SI
44(97.8%)
1(2.2%)
 45 (91.8%) 4 (8.2%)
10 DATA ENTRADA A LLISTA D'ESPERA TXC [POSIXct, POSIXt] min : 2015-09-16 med : 2019-01-20 12:00:00 max : 2020-12-10 range : 5y 2m 24d 42 distinct values 44 (89.8%) 5 (10.2%)
11 TEMPS EN LLISTA TRASPLANTAMENT [numeric] Mean (sd) : 248.6 (211.2) min < med < max: 21 < 181 < 735 IQR (CV) : 280.5 (0.8) 35 distinct values 35 (71.4%) 14 (28.6%)
12 Nº INGRESSOS EN L'ÚLTIM ANY PER DESCOMPENSACIÓ [numeric] Mean (sd) : 1.4 (1.4) min < med < max: 0 < 1 < 5 IQR (CV) : 2 (1)
0:14(31.1%)
1:16(35.6%)
2:5(11.1%)
3:5(11.1%)
4:3(6.7%)
5:2(4.4%)
 45 (91.8%) 4 (8.2%)
13 ASA [numeric] Min : 3 Mean : 4 Max : 4
3:2(4.4%)
4:43(95.6%)
 45 (91.8%) 4 (8.2%)
14 CLASSE FUNCIONAL: NYHA [numeric] Mean (sd) : 2.9 (0.7) min < med < max: 1 < 3 < 4 IQR (CV) : 0 (0.3)
1:3(6.7%)
2:5(11.1%)
3:30(66.7%)
4:7(15.6%)
 45 (91.8%) 4 (8.2%)
15 INTERMACS [numeric] Mean (sd) : 5 (1.2) min < med < max: 2 < 5 < 7 IQR (CV) : 2 (0.2)
2:1(2.4%)
3:1(2.4%)
4:14(33.3%)
5:14(33.3%)
6:5(11.9%)
7:7(16.7%)
 42 (85.7%) 7 (14.3%)
16 Charlson [numeric] Mean (sd) : 4.5 (2.2) min < med < max: 1 < 4 < 9 IQR (CV) : 3 (0.5)
1:5(11.1%)
2:2(4.4%)
3:11(24.4%)
4:5(11.1%)
5:9(20.0%)
6:4(8.9%)
7:4(8.9%)
8:3(6.7%)
9:2(4.4%)
 45 (91.8%) 4 (8.2%)
17 DASI [numeric] Mean (sd) : 17.2 (10.7) min < med < max: 4.4 < 15.2 < 50.7 IQR (CV) : 11.1 (0.6) 25 distinct values 43 (87.8%) 6 (12.2%)
18 CSHA [character] 1. 2 Bé, actiu ocasional 2. 3 Problemes mèdicos ben c 3. 4 Vulnerable, símptomes l 4. 5 Fragilitat lleu 5. 6 Fragilitat moderada, re 6. 7 Fragilitat severa, comp
1(2.2%)
3(6.7%)
25(55.6%)
11(24.4%)
3(6.7%)
2(4.4%)
 45 (91.8%) 4 (8.2%)
19 COMORBIDITATS (choice=HTA) [character] 1. 0 2. 1 3. No=0 4. Sí=1
20(42.6%)
25(53.2%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
20 COMORBIDITATS (choice=DSLP) [character] 1. 0 2. 1 3. No=0 4. Sí=1
25(53.2%)
20(42.6%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
21 COMORBIDITATS (choice=DM) [character] 1. 0 2. 1 3. No=0 4. Sí=1
31(66.0%)
14(29.8%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
22 COMORBIDITATS (choice=VASCULOPATIA) [character] 1. 0 2. 1 3. No=0 4. Sí=1
38(80.9%)
7(14.9%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
23 COMORBIDITATS (choice=IAM) [character] 1. 0 2. 1 3. No=0 4. Sí=1
25(53.2%)
20(42.6%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
24 COMORBIDITATS (choice=HIPOTIROIDISME) [character] 1. 0 2. 1 3. No=0 4. Sí=1
40(85.1%)
5(10.6%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
25 COMORBIDITATS (choice=SAHS) [character] 1. 0 2. 1 3. No=0 4. Sí=1
40(85.1%)
5(10.6%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
26 COMORBIDITATS (choice=AVC) [character] 1. 0 2. 1 3. No=0 4. Sí=1
38(80.9%)
7(14.9%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
27 COMORBIDITATS (choice=MPOC, ASMA) [character] 1. 0 2. 1 3. No=0 4. Sí=1
35(74.5%)
10(21.3%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
28 COMORBIDITATS (choice=IRC) [character] 1. 0 2. 1 3. No=0 4. Sí=1
27(57.4%)
18(38.3%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
29 COMORBIDITATS (choice=OBESITAT) [character] 1. 0 2. 1 3. No=0 4. Sí=1
36(76.6%)
9(19.1%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
30 COMORBIDITATS (choice=CIRURGIA CARDÍACA PRÈVIA) [character] 1. 0 2. 1 3. No=0 4. Sí=1
31(66.0%)
14(29.8%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
31 MEDICACIÓ ACTUAL (choice=BETABLOQUEJANTS) [character] 1. 0 2. 1 3. No=0 4. Sí=1
10(21.3%)
35(74.5%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
32 MEDICACIÓ ACTUAL (choice=VERAPAMIL / DILTIAZEM) [character] 1. 0 2. 1 3. No=0 4. Sí=1
43(91.5%)
2(4.3%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
33 MEDICACIÓ ACTUAL (choice=ESTATINES) [character] 1. 0 2. 1 3. No=0 4. Sí=1
23(48.9%)
22(46.8%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
34 MEDICACIÓ ACTUAL (choice=AMIODARONA) [character] 1. 0 2. 1 3. No=0 4. Sí=1
31(66.0%)
14(29.8%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
35 MEDICACIÓ ACTUAL (choice=LEVOSIMENDAN) [character] 1. 0 2. 1 3. No=0 4. Sí=1
30(63.8%)
15(31.9%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
36 MEDICACIÓ ACTUAL (choice=ANTICOAGULANTS ORALS) [character] 1. 0 2. 1 3. No=0 4. Sí=1
17(36.2%)
28(59.6%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
37 MEDICACIÓ ACTUAL (choice=SALBUTAMOL) [character] 1. 0 2. 1 3. No=0 4. Sí=1
43(91.5%)
2(4.3%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
38 MEDICACIÓ ACTUAL (choice=NITRATS) [character] 1. 0 2. 1 3. No=0 4. Sí=1
39(83.0%)
6(12.8%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
39 MEDICACIÓ ACTUAL (choice=DIGOXINA) [character] 1. 0 2. 1 3. No=0 4. Sí=1
36(76.6%)
9(19.1%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
40 DATA INICI LEVOSIMENDAN [POSIXct, POSIXt] min : 2016-10-21 med : 2018-07-06 max : 2020-06-06 range : 3y 7m 16d 15 distinct values 15 (30.6%) 34 (69.4%)
41 Tratamiento con Levosimendán [character] 1. 0 2. 1 3. No=0 4. Sí=1
27(58.7%)
17(37.0%)
1(2.2%)
1(2.2%)
 46 (93.9%) 3 (6.1%)
42 Inicio Levosimendán [character] 1. Inicio antes de prehab 2. Inicio despues de prehab
16(94.1%)
1(5.9%)
 17 (34.7%) 32 (65.3%)
43 HIPERTENSIÓ PULMONAR [character] 1. LLEUGERA 2. MODERADA 3. NO 4. SEVERA
8(17.8%)
11(24.4%)
12(26.7%)
14(31.1%)
 45 (91.8%) 4 (8.2%)
44 Tratamiento de la HTP [character] 1. No 2. Yes
29(65.9%)
15(34.1%)
 44 (89.8%) 5 (10.2%)
45 Fármaco (choice=Bosentán) [character] 1. 0 2. 1 3. No=0 4. Sí=1
33(70.2%)
12(25.5%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
46 Fármaco (choice=Sildenafilo) [character] 1. 0 2. 1 3. No=0 4. Sí=1
37(78.7%)
8(17.0%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
47 VALVULOPATIA? [character] 1. 0 2. 1 3. No=0 4. Sí=1
6(12.8%)
39(83.0%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
48 Insuficiència / Estenosis? [character] 1. Estenosis 2. Insuficiència
1(2.6%)
38(97.4%)
 39 (79.6%) 10 (20.4%)
49 Vàlvula/es afectada (choice=MITRAL) [character] 1. 0 2. 1 3. No=0 4. Sí=1
13(27.7%)
32(68.1%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
50 Vàlvula/es afectada (choice=AÒRTICA) [character] 1. 0 2. 1 3. No=0 4. Sí=1
42(89.4%)
3(6.4%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
51 Vàlvula/es afectada (choice=TRICÚSPIDE) [character] 1. 0 2. 1 3. No=0 4. Sí=1
31(66.0%)
14(29.8%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
52 Vàlvula/es afectada (choice=PULMONAR) [character] 1. 0 2. No=0 3. Sí=1
45(95.7%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
53 GRAU DE SEVERITAT (choice=LLEU) [character] 1. 0 2. 1 3. No=0 4. Sí=1
37(78.7%)
8(17.0%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
54 GRAU DE SEVERITAT (choice=MODERADA) [character] 1. 0 2. 1 3. No=0 4. Sí=1
26(55.3%)
19(40.4%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
55 GRAU DE SEVERITAT (choice=SEVERA) [character] 1. 0 2. 1 3. No=0 4. Sí=1
32(68.1%)
13(27.7%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
56 FRACCIÓ D'EJECCIÓ VE % [numeric] Mean (sd) : 27.4 (13.1) min < med < max: 12 < 21 < 65 IQR (CV) : 10 (0.5) 17 distinct values 45 (91.8%) 4 (8.2%)
57 ARRÍTMIA (choice=NO) [character] 1. 0 2. 1 3. No=0 4. Sí=1
31(66.0%)
14(29.8%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
58 ARRÍTMIA (choice=ACXFA) [character] 1. 0 2. 1 3. No=0 4. Sí=1
20(42.6%)
25(53.2%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
59 ARRÍTMIA (choice=BAV) [character] 1. 0 2. 1 3. No=0 4. Sí=1
43(91.5%)
2(4.3%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
60 ARRÍTMIA (choice=ALTRES) [character] 1. 0 2. 1 3. No=0 4. Sí=1
34(72.3%)
11(23.4%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
61 PORTADOR MCP O DAI (choice=NO) [character] 1. 0 2. 1 3. No=0 4. Sí=1
37(78.7%)
8(17.0%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
62 PORTADOR MCP O DAI (choice=MARCAPAS) [character] 1. 0 2. 1 3. No=0 4. Sí=1
40(85.1%)
5(10.6%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
63 PORTADOR MCP O DAI (choice=DAI) [character] 1. 0 2. 1 3. No=0 4. Sí=1
10(21.3%)
35(74.5%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
64 Asistencia ventricular previa al TxC? [character] 1. No 2. Yes
28(93.3%)
2(6.7%)
 30 (61.2%) 19 (38.8%)
65 ÚS DE TICS PROPOSAT (choice=CAP) [character] 1. 0 2. 1 3. No=0 4. Sí=1
2(4.3%)
43(91.5%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
66 ÚS DE TICS PROPOSAT (choice=FIT BIT) [character] 1. 0 2. No=0 3. Sí=1
45(95.7%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
67 ÚS DE TICS PROPOSAT (choice=NUUBO) [character] 1. 0 2. 1 3. No=0 4. Sí=1
43(91.5%)
2(4.3%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
68 ÚS DE TICS PROPOSAT (choice=PODÒMETRE) [character] 1. 0 2. No=0 3. Sí=1
45(95.7%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
69 ÚS DE TICS PROPOSAT (choice=APP SMARTPHONE) [character] 1. 0 2. No=0 3. Sí=1
45(95.7%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
70 ENTRENAMENT PROPOSAT (choice=NO ENTRENAMENT) [character] 1. 0 2. No=0 3. Sí=1
45(95.7%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
71 ENTRENAMENT PROPOSAT (choice=GYM PREHAB) [character] 1. 1 2. No=0 3. Sí=1
45(95.7%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
72 ENTRENAMENT PROPOSAT (choice=HOME-BASED) [character] 1. 0 2. No=0 3. Sí=1
45(95.7%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
73 ENTRENAMENT PROPOSAT (choice=GIMNÀS PROPI) [character] 1. 0 2. No=0 3. Sí=1
45(95.7%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
74 NUTRICIÓ PROPOSADA (choice=VISITA INDIVIDUALITZADA) [character] 1. 0 2. 1 3. No=0 4. Sí=1
1(2.1%)
44(93.6%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
75 NUTRICIÓ PROPOSADA (choice=VISITA GRUPAL) [character] 1. 0 2. 1 3. No=0 4. Sí=1
43(91.5%)
2(4.3%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
76 RESULTAT SGA-SF [character] 1. A 2. B 3. C
20(46.5%)
21(48.8%)
2(4.7%)
 43 (87.8%) 6 (12.2%)
77 INDICAT SUPLEMENTACIÓ NUTRICIONAL? [character] 1. 0 2. 1 3. No=0 4. Sí=1
7(14.9%)
38(80.9%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
78 TIPUS DE SUPLEMENTACIÓ [character] 1. HIPERPROTEICA 2. HIPERPROTEICA HIPER CALÒR
33(86.8%)
5(13.2%)
 38 (77.6%) 11 (22.4%)
79 GRAMS PROTEÏNA / DIA [numeric] Mean (sd) : 56.3 (11.1) min < med < max: 28 < 60 < 80 IQR (CV) : 10 (0.2)
28:1(2.6%)
38:1(2.6%)
40:3(7.9%)
44:1(2.6%)
50:10(26.3%)
60:14(36.8%)
70:7(18.4%)
80:1(2.6%)
 38 (77.6%) 11 (22.4%)
80 FERRO INDICAT? [character] 1. ENDOVENÓS 2. NO 3. ORAL
10(22.2%)
34(75.6%)
1(2.2%)
 45 (91.8%) 4 (8.2%)
81 QUANTITAT FERRO ENDOVENÓS [logical] All NA's 0 (0.0%) 49 (100.0%)
82 PROPOSAT PER A MINDFULNESS? [character] 1. 0 2. 1 3. No=0 4. Sí=1
6(13.6%)
36(81.8%)
1(2.3%)
1(2.3%)
 44 (89.8%) 5 (10.2%)
83 PROPOSAT PER A FISIOTERÀPIA RESPIRATÒRIA? [character] 1. 0 2. 1 3. No=0 4. Sí=1
1(2.1%)
44(93.6%)
1(2.1%)
1(2.1%)
 47 (95.9%) 2 (4.1%)
84 DESHABITUACIÓ TABÀQUICA? [character] 1. NO 2. NO INDICAT 3. SI
6(13.3%)
37(82.2%)
2(4.4%)
 45 (91.8%) 4 (8.2%)
85 Complete? [character] 1. Complete
45(100.0%)
 45 (91.8%) 4 (8.2%)

Generated by summarytools 0.9.9 (R version 4.0.2)
2021-06-27